Columbia Laboratories, Inc. (CBRX) Misses Q3 EPS by 1c

Columbia Laboratories, Inc. (NASDAQ: CBRX) reported Q3 EPS of $0.00, $0.01 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $6.7 million versus the consensus estimate of $7 million.

For earnings history and earnings-related data on Columbia Laboratories, Inc. (CBRX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
• UBS Upgrades Deterra Royalties Ltd (DRR:AU) to Buy
• BMO Capital Starts National Energy Services Reunited (NESR) at Outperform